Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis

Journal of Thrombosis and Haemostasis

Volumn 14, Issue 9, 2016, Pages 1749-1758

  Neshat Vahid, S ^a   Pierce, R ^a   Hersey, D ^a   Raffini, L J ^b   Faustino, E V S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

central venous catheter; factor V Leiden; factor VIII; protein C deficiency; venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ARTICLE; ASYMPTOMATIC DISEASE; BIOLOGICAL TRAIT; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; HEMOPHILIA A; HUMAN; META ANALYSIS; MUTATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; THROMBOPHILIA;

EID: 84988487593     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13388     Document Type: Article

References (43)

1. Monagle P, Adams M, Mahoney M, Ali K, Barnard D, Bernstein M, Brisson L, David M, Desai S, Scully MF, Halton J, Israels S, Jardine L, Leaker M, McCusker P, Silva M, Wu J, Anderson R, Andrew M, Massicotte MP. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 763–6.
2. Raffini L, Thornburg C. Testing children for inherited thrombophilia: more questions than answers. Br J Haematol 2009; 147: 277–88.
3. Monagle P, Chan AK, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Gottl U, Vesely SK. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e737S–801S.
4. Vidal E, Sharathkumar A, Glover J, Faustino EV. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis. J Thromb Haemost 2014; 12: 1096–109.
5. Raffini L. Thrombophilia in children: who to test, how, when, and why? Hematology Am Soc Hematol Educ Program 2008; 2008: 228–35.
6. Middeldorp S. Is thrombophilia testing useful? Hematology Am Soc Hematol Educ Program 2011; 2011: 150–5.
7. Young G, Albisetti M, Bonduel M, Brandao L, Chan A, Friedrichs F, Goldenberg NA, Grabowski E, Heller C, Journeycake J, Kenet G, Krumpel A, Kurnik K, Lubetsky A, Male C, Manco-Johnson M, Mathew P, Monagle P, van Ommen H, Simioni P, et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation 2008; 118: 1373–82.
8. Holzhauer S, Goldenberg NA, Junker R, Heller C, Stoll M, Manner D, Mesters R, Krumpel A, Stach M, Nowak-Gottl U. Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study. Blood 2012; 120: 1510–15.
9. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, Stewart L. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev 2012; 1: 2.
10. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008–12.
11. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006; 295: 676–80.
12. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. Cochrane Bias Methods Group, Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
13. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol 2006; 163: 197–203.
14. Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 2002; 359: 781–5.
15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–88.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–60.
17. Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004; 23: 1663–82.
18. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953; 9: 531–41.
19. Daly LE. Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol 1998; 147: 783–90.
20. Abdelkefi A, Ben Romdhane N, Kriaa A, Chelli M, Torjman L, Ladeb S, Ben Othman T, Lakhal A, Guermazi S, Ben Hassen A, Ladeb F, Ben Abdeladhim A. Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients. Bone Marrow Transplant 2005; 36: 885–9.
21. Nowak-Gottl U, Dubbers A, Kececioglu D, Koch HG, Kotthoff S, Runde J, Vielhaber H. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr 1997; 131: 608–12.
22. Knofler R, Siegert E, Lauterbach I, Taut-Sack H, Siegert G, Gehrisch S, Muller D, Rupprecht E, Kabus M. Clinical importance of prothrombotic risk factors in pediatric patients with malignancy – impact of central venous lines. Eur J Pediatr 1999; 158 (Suppl. 3): S147–50.
23. Wermes C, von Depka Prondzinski M, Lichtinghagen R, Barthels M, Welte K, Sykora KW. Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters. Eur J Pediatr 1999; 158(Suppl. 3): S143–6.
24. Ruud E, Holmstrom H, Natvig S, Wesenberg F. Prevalence of thrombophilia and central venous catheter-associated neck vein thrombosis in 41 children with cancer – a prospective study. Med Pediatr Oncol 2002; 38: 405–10.
25. Mitchell LG, Andrew M, Hanna K, Abshire T, Halton J, Anderson R, Cherrick I, Desai S, Mahoney D, McCuster P, Wu J, Dahl G, Chait P, de Veber G, Lee KJ, Mikulis D, Ginsberg J, Way C; Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase Group. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer 2003; 97: 508–16.
26. Finkelstein Y, Yaniv I, Berant M, Zilber R, Garty BZ, Epstein O, Lahav J, Tamary H. Central venous line thrombosis in children and young adults with thalassemia major. Pediatr Hematol Oncol 2004; 21: 375–81.
27. Dubois J, Rypens F, Garel L, David M, Lacroix J, Gauvin F. Incidence of deep vein thrombosis related to peripherally inserted central catheters in children and adolescents. CMAJ 2007; 177: 1185–90.
28. Farinasso L, Bertorello N, Garbarini L, Gajno TM, Barisone E, Artesani L, Valori A, Giacchino M, Pastore G, Saracco P. Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study. Leukemia 2007; 21: 552–6.
29. Lipay NV, Dmitriev VV, Borisenok MB. Thrombotic complications during cancer treatment in children. Exp Oncol 2007; 29: 231–35.
30. Turebylu R, Salis R, Erbe R, Martin D, Lakshminrusimha S, Ryan RM. Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis. J Perinatol 2007; 27: 490–5.
31. Chung BH, Ma ES, Khong PL, Chan GC. Inherited thrombophilic factors do not increase central venous catheter blockage in children with malignancy. Pediatr Blood Cancer 2008; 51: 509–12.
32. Rask O, Bjorgell O, Wattsgard C, Ljung R. High frequency of asymptomatic thrombosis associated with central venous lines in children with haemophilia. J Thromb Haemost 2011; 9: 462–3.
33. Albisetti M, Kellenberger CJ, Bergstrasser E, Niggli F, Kroiss S, Rizzi M, Schmugge M. Port-a-cath-related thrombosis and postthrombotic syndrome in pediatric oncology patients. J Pediatr 2013; 163: 1340–6.
34. Thom K, Male C, Mannhalter C, Quehenberger P, Mlczoch E, Luckner D, Marx M, Hanslik A. No impact of endogenous prothrombotic conditions on the risk of central venous line-related thrombotic events in children: results of the KIDCAT study (KIDs with Catheter Associated Thrombosis). J Thromb Haemost 2014; 12: 1610–15.
35. Faustino EV, Li S, Silva CT, Pinto MG, Qin L, Tala JA, Rinder HM, Kupfer GM, Shapiro ED, for the Northeast Pediatric Critical Care Research Consortium. Factor VIII may predict catheter-related thrombosis in critically ill children: a preliminary study. Pediatr Crit Care Med 2015; 16: 497–504.
36. Munck A, Kheniche A, Alberti C, Hubert D, Martine RG, Nove-Josserand R, Pin I, Bremont F, Chiron R, Couderc L, Dalphin ML, Darviot E, Delaisi B, Dominique S, Durieu I, Fanton A, Fayon M, Gerardin M, Ginies JL, Giraut C, et al. Central venous thrombosis and thrombophilia in cystic fibrosis: a prospective study. J Cyst Fibros 2015; 14: 97–103.
37. Kenet G, Strauss T, Kaplinsky C, Paret G. Hemostasis and thrombosis in critically ill children. Semin Thromb Hemost 2008; 34: 451–8.
38. Boersma RS, Hamulyak K, Cate HT, Schouten HC. Congenital thrombophilia and central venous catheter-related thrombosis in patients with cancer. Clin Appl Thromb Hemost 2010; 16: 643–9.
39. Faustino EV, Spinella PC, Li S, Pinto MG, Stoltz P, Tala J, Card ME, Northrup V, Baker KE, Goodman TR, Chen L, Silva CT. Incidence and acute complications of asymptomatic central venous catheter-related deep venous thrombosis in critically ill children. J Pediatr 2013; 162: 387–91.
40. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, Mackie I, Makris M, Nokes T, Perry D, Tait RC, Walker I, Watson H. British Committee for Standards in Haematology. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 2010; 149: 209–20.
41. O'Brien SH, Smith KJ. Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective. J Pediatr 2009; 155: 100–4.
42. Saber W, Moua T, Williams EC, Verso M, Agnelli G, Couban S, Young A, De Cicco M, Biffi R, van Rooden CJ, Huisman MV, Fagnani D, Cimminiello C, Moia M, Magagnoli M, Povoski SP, Malak SF, Lee AY. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost 2011; 9: 312–19.
43. Mitchell LG, Goldenberg NA, Male C, Kenet G, Monagle P, Nowak-Gottl U, on behalf of the Perinatal and Paediatric Haemostasis Subcommittee of the SSC of the ISTH. Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children. J Thromb Haemost 2011; 9: 1856–8.